Table 3:

Determinants of finding patients diagnosed with Kaposi’s sarcoma to perform rapid case ascertainment within 90 days of health system diagnosis at three clinical sites in sub-Saharan Africa.

	Unadjusted		Adjusted*
	Risk Ratio (95% CI)	P value	Risk Ratio (95% CI)	P value
Age of patient, per 1 year increase	1.00 (0.99 to 1.004)	0.44	1.00 (0.99 to 1.01)	0.84
Sex of patient
Women	Ref.		Ref.
Men	0.98 (0.84 to 1.13)	0.78	0.96 (0.84 to 1.1)	0.55
Facility
AMPATH, Kenya	Ref.		Ref.
Masaka-RRH, Uganda	1.4 (1.2 to 1.5)	<0.001	1.5 (1.3 to 1.7)	<0.001
Mbarara-RRH, Uganda	0.66 (0.51 to 0.87)	0.003	0.88 (0.70 to 1.1)	0.27
Mode of identification of patient
Clinician Notification	Ref.		Ref.
Electronic Medical Records	0.59 (0.40 to 0.89)	0.012	0.57 (0.39 to 0.85)	0.006
Pathology Laboratory Records	1.2 (1.1 to 1.4)	0.004	0.88 (0.73 to 1.1)	0.18
Dermatology or Oncology Clinic Records	0.056 (0.0082 to 0.38)	0.003	0.080 (0.012 to 0.54)	0.010
Medical Ward	0.61 (0.40 to 0.92)	0.019	0.55 (0.39 to 0.79)	0.001

^*Adjusted risk ratios were derived using modified Poisson regression in a generalized linear model with robust variance and log link function. All variables are adjusted for all variables in the column.

AMPATH denotes Academic Model Providing Access to Healthcare in western Kenya; Masaka-RRH denotes Masaka Regional Referral Hospital Uganda Cares in Masaka, Uganda; and Mbarara-RRH denotes Mbarara Regional Referral Hospital, Immune Suppressive Syndrome clinic in Mbarara, Uganda.